Erin Henry, PhD

Erin Henry, Ph.D. is a biotech executive/clinical researcher and strategist. Her most recent role was VP, Product Strategy & Project Team Lead Development at Iveric, turned Astellas Pharma. Prior to Iveric Bio, Erin was Executive Director of Clinical Research at NGM Bio where she oversaw the NGM621 Clinical Development Program for Geographic Atrophy as the Project Team Leader and Clinical Lead. Previously, Erin worked at Genentech, Inc for 13 years in the Medical Affairs, Product Development and Marketing Ophthalmology Franchise. Erin completed a Ph.D. from Vanderbilt University in Neurobiology and a Post-doctoral Fellowship in the Department of Ophthalmology from Washington University in St. Louis.